home / stock / lxrx / lxrx news

LXRX News and Press, Lexicon Pharmaceuticals Inc. From 06/01/23

Stock Information
Company Name: Lexicon Pharmaceuticals Inc.
Stock Symbol: LXRX
Market: NASDAQ
Website: lexpharma.com
Menu
LXRX LXRX Quote LXRX Short LXRX News LXRX Articles LXRX Message Board
Get LXRX Alerts

News, Short Squeeze, Breakout and More Instantly...
LXRX - Lexicon Pharmaceuticals Secures Key FDA Approval, But Heavy Lifting Remains

2023-06-01 11:28:37 ET Summary Lexicon Pharmaceuticals received FDA approval to market its heart failure drug Inpefa, as well as a broad label compared to rivals like AstraZeneca's Farxiga and Lilly's Jardiance. The company faces significant challenges in marketing Inpefa against ...
LXRX - Nanobiotix, Veeva top healthcare gainers; Lexicon, Adicet among losers

2023-06-01 10:07:16 ET Gainers: Nanobiotix ( NBTX ) +17% . Veeva Systems ( VEEV ) +13% . Biohaven ( BHVN ) +12% . Rockwell Medical ( RMTI ) +11% . Quipt Home Medical ( QIPT ) +9% . Losers: Lexicon Pharmaceuticals ( LXRX ...

LXRX - TRVN, MRKR and EVTL among pre-market losers

2023-06-01 08:30:01 ET Okta OKTA -19% after Q1earning release . Lexicon Pharmaceuticals ( LXRX ) -18% announces pricing of $125 Million public offering and concurrent private placement. C3.ai AI -17% after Q4 earning release . Victoria's Secret &...

LXRX - Lexicon Announces Pricing of $125 Million Public Offering and Concurrent Private Placement

THE WOODLANDS, Texas, June 01, 2023 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) (“ Lexicon ”) today announced the pricing of its previously announced underwritten public offering of 23,924,705 shares of its common stock, par value $0.001. The shares of c...
LXRX - MMAT, LXRX and LAB are among after hour movers

2023-05-31 17:19:57 ET Gainers: Red Cat Holdings ( RCAT ) +62% . Paltalk ( PALT ) +19% . Viant Technology  ( DSP ) +9% . Meta Materials ( MMAT ) +9% . VIZIO Holding  ( VZIO ) +8% . Losers: Lexicon Pharmaceutical...

LXRX - Lexicon Announces Proposed Public Offering of Common Stock

THE WOODLANDS, Texas, May 31, 2023 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) (“ Lexicon ”) today announced that it has commenced an underwritten public offering to offer and sell, subject to market and other conditions, shares of its common stock, par ...

LXRX - GEVO, LXRX and CRVS among mid-day movers

2023-05-30 13:14:47 ET Gainers: Atento ( ATTO ) +92% . Wearable Devices ( WLDS ) +86% . T2 Biosystems ( TTOO ) +55% . Arlington Asset Investment ( AAIC ) +45% . Equitrans Midstream Corporation ( ETRN ) +36% . The Glimpse Grou...
LXRX - RIOT, AI and IOVA are among pre market gainers

2023-05-30 08:34:33 ET Arlington Asset Investment  ( AAIC ) +53% Announce Definitive Merger Agreement. Equitrans Midstream  ( ETRN ) +33% . HeartBeam ( BEAT ) +28% Enters into Strategic Alliance Agreement with Samsung. Wearable Devices  (...

LXRX - Lexicon Announces FDA Approval of INPEFA(TM) (sotagliflozin) for Treatment of Heart Failure

INPEFA granted broad label across full range of left ventricular ejection fraction, including HFpEF and HFrEF, and for patients with or without diabetes INPEFA reduced the risk of total occurrence of cardiovascular death, hospitalization for heart failure, and urgent heart failure v...

LXRX - FRO, LXRX and GOTU are among pre market gainers

2023-05-26 08:34:32 ET Onfolio Holdings ( ONFO ) +62% Completes Development of Generative AI Search Tool. Elevation Oncology ( ELEV ) +58% . Quhuo Limited ( QH ) +37% Sector Exceeded RMB12 Million in Sales During the Labor Day Holiday, Achieving Impre...
Previous 10 Next 10